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Psidium guajava is a well known traditional medicinal plant and is used in 
various indigenous systems of medicine. The present research work aims at 
evaluating hepatoprotective activity of ethanolic extract of P. guajava and the 
phospholipid complex of the extract with phosphatidylcholine against 
paracetamol induced hepatic damage in albino rats. The hepatoprotective 
effect was studied on rat liver damage induced by paracetamol by monitoring 
serum parameters SGOT, SGPT, ALP, Total protein, Albumin, Globulin, 
Bilirubin and histopathological alterations. Significant hepatoprotective 
effects were observed against liver damage induced by paracetamol overdose 
as evident from decreased serum levels of SGOT, SGPT, ALP and bilirubin 
in the extract treated groups (200, 400 mg/kg) and phospholipid complex 
(100mg/kg) compared to the intoxicated controls. The hepatoprotective effect 
was further verified by histopathology of the liver. The phospholipid complex 
showed better activity than the plain extracts which was almost comparable 
to standard silymarin. The aqueous extracts of P. guajava and the 
phospholipid complex exhibited protective effect against paracetamol-
induced hepatotoxicity with the complex showing activity better than the 
plain extract. These results supported the use of this plant for the treatment of 
hepatitis in oriental traditional medicine. 
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Introduction 
Psidium guajava L (family Myrtaceae) is a native 
plant of tropical America. More recent 
ethnopharmacological studies show that Psidium 
guajava is used in many parts of the world for the 
treatment of a number of diseases, e.g. as an anti-
inflammatory, for diabetes, hypertension, carries, 
wounds, pain relief and reducing fever [1]. 
Leaves of this plant have been reported to contain 
several compounds such as various flavonoids 
[2], tannins [3] and terpenoids [4]. Quercetin is 
the best-known flavonoid from guava leaves [5].  
 
Phosphatidylcholine is a major constituent of cell 
membranes and it is freely compatible with other 
nutrients, and when coadministered may enhance 
their absorption. Several studies have 
demonstrated that complexation of phospholipids 
with phytoconstituents increases their 
bioavailability [6, 7]. 
Based on its diversified pharmacological 
properties, an attempt has been made to validate 
plant for its hepatoprotective potential against 
hepatotoxin paracetamol in experimental studies. 
doi:10.5138/ijpm.2010.0975.0185.02014 
©arjournals.org,  All  rights reserved. 
D’Mello et al: International Journal of Phytomedicine 2 (2010) 85-93 
 
 86
The in vivo hepatoprotective activity of 
phospholipid complex was evaluated and 
compared with plain extract in paracetamol-
induced hepatotoxicity in mice model. Its 
hepatoprotective effect was compared to the 
effect of standard silymarin which is known to be 
hepatoprotective against acetaminophen-induced 
liver damages. 
 
Materials and methods 
Plant material 
P. guajava (Myrtaceae) fresh tender leaves were 
collected from a local botanical garden and 
authenticated at the Department Of 
Pharmacognosy and Phytochemistry, Prin. 
K.M.Kundnani College of Pharmacy. The leaves 
were dried at 40°C in hot air oven for 24 hrs to 
remove any moisture present. 
 
Preparation of extracts 
Dried and powdered leaves of P.guajava were 
extracted by using ethanol in soxhlet apparatus. 
The total extract obtained was dried at 60 °C on 
steam bath followed by a vacuum oven (50 °C) to 
obtain dried extracts. The extractive value was 
calculated as % w/w yield and was found to be 
5.77%. 
 
Preparation of phosphatidylcholine complexes 
of extract of P. guajava and its 
characterization 
The complex was prepared with extract/ 
quercetin and phospholipid at a molar ratio of 
1:2.Weighed amount of extract/ quercetin and 
phospholipid were taken in a 250 ml round 
bottom flask and dichloromethane was added. 
The mixture was refluxed at a temperature not 
exceeding 60 ◦C for 2 h. The resultant clear 
solution was evaporated and the resultant mixture 
was then added to n-hexane with continuous 
stirring. The complex was precipitated and the 
precipitate was filtered and dried under vacuum 
to remove traces of solvents. The resultant 
complex was kept in an amber colored glass 
bottle, and stored [8]. 
The phospholipid complex of extract and 
quercetin were characterized by Nuclear 
Magnetic Resonance spectroscopy (NMR) and 
Fourier transform infrared (FTIR) spectroscopy. 
The H-NMR spectrums of quercetin, Plant 
complex and quercetin complex are obtained in 
DMSO. 
For FT-IR, DRS (Diffuse reflectance attachment) 
is used to measure a diffuse reflection spectrum 
of a powder sample. The quercetin was analyzed 
by DRS. KBr Fixed thickness cell is used to 
measure liquid samples. Thus the phospholipid 
complex of extract and quercetin was analyzed by 
preparing solution in dichloromethane. 
 
Experimental animals 
Albino Wistar rats (either sex) weighing 200-250 
g were obtained from the Glenmark 
Pharmaceuticals Ltd. The rats were acclimatized 
to laboratory conditions. They were housed in 
plastic cages, maintained under 12 h dark light 
cycle, fed with standard pellet diet and water ad 
libitum. All the experimental procedure and 
protocols used in the study were approved by 
IAEC of K.M.K.College of Pharmacy, Cuffe 
Parade, and as per CPCSEA guidelines. Protocol 
number is 080910. 
 
Paracetamol induced hepatotoxicity 
The model described by Feng-Lin Yen and Tzu-
Hui Wu, 2006 [9] was employed with some 
modifications. Twenty eight rats were randomly 
divided into seven groups each containing four 
animals. Group I received saline (10 ml/kg, i.p.) 
as normal control for seven days; group II 
received Paracetamol 835mg/kg (in olive oil w/v 
p.o.) as treated control group; group III received 
silymarin extract (25 mg/kg, i.p.) as the standard 
reference; groups IV and V received Psidium 
guajava extract with doses of 200 and 400 mg/kg, 
respectively, for seven consecutive days; group 
VI received phospholipid complex at 100 mg/kg 
p.o., for seven consecutive days and group VII 
received quercetin at 25 mg/kg p.o., for seven 
consecutive days. Paracetamol was administered 
to the animals of Group III, IV, V, VI and VII in 
a single dose of paracetamol 835mg/kg (in olive 
oil w/v p.o.) on the seventh day. Animals in all 
the groups were sacrificed 24 h after paracetamol 
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administration. The rats were sacrificed on the 8th 
day under light ether anesthesia. The blood was 
obtained from all animals by puncturing retro-
orbital plexus; serum was separated by 
centrifugation at 3000 rpm by the pathological 
centrifuge. The serum parameters SGOT, SGPT, 
ALP, Total protein, Albumin, Globulin and 
Bilirubin were estimated. The liver tissue was 




The experimental results were expressed as the 
Mean ± SEM for four animals in each group. The 
biochemical parameters were analyzed 
statistically using one-way analysis of variance 
ANOVA, followed by Dunnett’s multiple 
comparison test (DMCT). P value of < 0.05 was 
considered as statistically significant. 
 
Results 
Characterization of phospholipid complex of 
extract and quercetin: 
The formation of a complex is confirmed by a 
NMR spectroscopy study of the proton, by 
comparing the spectra of the individual 
constituents with those of the reaction product 
(quercetin) In the complex's 1 H-NMR spectrum, 
the signals of the protons characteristics of the 
flavonoid molecule are not detectable, or are very 
enlarged, whereas the protons belonging to the 
lipid can be observed. Clearly apparent in the 
same spectrum is a broadening of the band of N-
(Me)3 group of choline, showing that this moiety 
is involved in the complex formation. The 
complex compound obtained is lipophilic in 
nature and is soluble in non polar and aprotic 
solvents. 
There is complete disappearance of proton 
signals in complexes of extract (Fig. 2) and 
quercetin (Fig. 3) which were present in the 
quercetin (Fig. 1). Such evidences inferred that 
the two long aliphatic chains are wrapped around 
the active principle, producing a lipophilic 
envelope, which shields the polar head of the 
phospholipid and the flavonoid molecule. 
IR of quercetin showed 3265.49, 3282.84, 
3323.35, 3404.36, 3630.03 values representing 
the OH stretching which confirms the presence of 
–OH groups, 1664.57 confirms the presence of 
C=O and 1521.84, 1612.49 values confirm the 
presence of aromatic structure in quercetin. 
IR of phospholipid complex of extract showed 
3480.70, 3502.88 values representing the –OH 
groups which are less as compared to quercetin 
which confirms the complexation of polyphenols 
with phospholipid. 
IR of Quercetin Phospholipid complex showed 
3313.71, 3676.32 values representing the –OH 
groups which are less as compared to quercetin 
which confirms the complexation of quercetin 
with phospholipid. 
 
    Figure1. Quecetin  1H NMR 
 
Antihepatotoxic activity 
A significant elevation in the levels of SGOT, 
SGPT, ALP and Bilirubin were observed with the 
administration of the toxicant paracetamol in 
group II as shown in table 1. The standard and 
treatment groups P. guajava extract 200mg/kg, 
400mg/kg and quercetin respectively 
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demonstrated reduction in the levels of the 
enzymes. Phospholipid complex showed 
significant reduction in the levels of enzymes 
(p<0.01) as compared to extract. 
 
 
Figure 2. Plant extract phospholipid complex 
1H NMR 
 
A significant reduction in the levels of Albumin, 
Globulin and Total protein were observed with 
the administration of the toxicant paracetamol in 
group II. The standard, quercetin and treatment 
groups P. guajava extract 200mg/kg, 400mg/kg 
respectively demonstrated elevation in the levels 
of the enzymes. Phospholipid complex showed 
significant elevation in the levels of above 
mentioned parameters as compared to extract. 
Administration of higher dose of the Psidium 
guajava extract 400 mg/kg showed a better 
hepatoprotective activity than the 200 mg/kg dose 
indicating dose dependant activity; however the 




The rats treated with a vehicle control (Fig. 7) 
showed a normal hepatic architecture. The liver 
samples of paracetamol treated rats showed 
multifocal moderate to marked degree, marked 
diffuse granular degeneration, mildly multifocal 
mild periportal lymphocytic infiltration (Fig. 8). 
The Histopathological pattern of the livers of the 
rats treated with paracetamol plus extract 
200mg/kg showed moderate diffuse granular 
degeneration, minimal to mild multifocal, mild 
lobular disarray (Fig.10) whereas 400 mg/kg dose 
showed mild diffuse granular degeneration, 
minimal multifocal periportal lymphocytic 
infiltration (Fig. 11). However the phospholipid 
complex treated rat showed multifocal minimal 
degree, mild diffuse granular degeneration (Fig. 








Paracetamol-induced hepatic injuries is the 
commonly used experimental model for the 
screening of hepatoprotective drugs [10, 11]  and 
the extent of hepatic damage is assessed by the 
level of released cytoplasmic enzymes (ALP, 
 88
D’Mello et al: International Journal of Phytomedicine 2 (2010) 85-93 
 
This highly reactive metabolite, N-acetyl-p-
benzoquinoneimine [18] capable of binding 
covalently to cellular macromolecules (proteins, 
DNA) to produce protein adducts. 
SGOT and SGPT) in circulation [12, 13]. 
Leakage of cellular enzymes into plasma 
indicates a hallmark sign of hepatic injury or 






























Figure 4. Hepatoprotective action of Psidium 
guajava in rats: serum enzyme activity of 
SGPT, SGOT and ALP among different 
treatment groups. Values are mean± S.E.M (n 
= 4) 
Figure 6. Hepatoprotective action of Psidium 
guajava in rats: serum enzyme activity of 
Bilirubin among different treatment groups. 
Values are mean± S.E.M (n = 4) 
 
 In living systems, liver is considered to be highly 
sensitive to toxic agents. The study of different 
enzyme activities such as SGOT, SGPT, ALP, 
total bilirubin and total protein have been found 
to be of great value in the assessment of clinical 
and experimental liver damage [19]. 
Paracetamol is mainly metabolized in the liver by 
glucuronidation and sulfation [16]. However, 
hepatotoxicity of paracetamol has been attributed 
to the formation of a toxic reactive metabolite 
where a part of paracetamol is activated by the 



















Figure 5. Hepatoprotective action of Psidium 
guajava in rats: serum enzyme activity of 
Albumin, Globulin and Total protein among 
different treatment groups. Values are mean± 
S.E.M (n = 4) 
Figure 7.  Section of liver of normal control rat 
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Treatment of the rats with P. guajava extracts at 
200 mg/kg, 400 mg/kg and phospholipid complex 
100mg/kg, orally, for 7 days before paracetamol 
administration, resulted in a significant reduction 
of paracetamol-induced elevation of serum 
marker enzymes and appears to be protective in 
reducing the injurious effect of paracetamol 
observed in the study. Silymarin is a known 
hepatoprotective compound obtained from 
Silybum marianum. It is reported to have a 
protective effect on plasma membrane of 




Figure 8. Section of paracetamol overdose-
treated rat liver showing Multifocal moderate 
to marked degree, marked diffuse granular 
degeneration, mildly multifocal mild 
periportal lymphocytic infiltration. 
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Figure 9. Section of Silymarin (25 mg/kg) + 
paracetamol overdose-treated rat liver 
showing mild diffuse granular degeneration. 
 
This is an indication of the stabilization of plasma 
membrane, as well as repair of hepatic tissue 




Figure 10. Section of P. guajava (200 mg/kg) + 
paracetamol overdose-treated rat liver 
showing Moderate diffuse granular 
degeneration, minimal to mild multifocal, mild 
lobular disarray. 
 
Prophylactic and curative treatment with extract 
and phospholipid complex restored all the 
enzymes studied and bilirubin in a dose 
dependent manner showing its potential to 
maintain the normal functional status of the liver. 
The possible mechanism may be that the 
antioxidant activity of flavonoids like quercetin 
present in the extract of P. guajava can scavenge 





Figure 11. Section of P. guajava (400 mg/kg) + 
paracetamol overdose-treated rat liver 
showing mild diffuse granular degeneration, 
minimal multifocal periportal lymphocytic 
infiltration. 
 
The histopathological observations in 
paracetamol-treated rats showed severe necrosis, 




Figure 12. Section of Phospholipid complex 
(100 mg/kg) + paracetamol overdose-treated 
rat liver showing multifocal minimal degree, 
mild diffuse granular degeneration. 
 
This could be due to the formation of highly 
reactive radicals because of oxidative threat 
caused by paracetamol. All these changes were 
very much reduced histopathologically in rats 
treated with extract and complex. 
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Figure 13. Section of quercetin (25 mg/kg) + 
paracetamol overdose-treated rat liver 
showing minimal diffuse granular 
degeneration. 
 
Based on the above results, it could be concluded 
that the phospholipid complex exerts significant 
hepatoprotection than the extract against 
paracetamol-induced toxicity. The extract showed 
significant activity against paracetamol induced 
liver damage in rats in a dose dependant manner. 
The enhanced activity of phospholipid complex 
of P. guajava could be because of its higher 




In conclusions, the aqueous extracts of Psidium 
guajava and the phospholipid complex exhibited 
protective effect against paracetamol-induced 
hepatotoxicity. Further studies are required to 
isolate the active constituents involved in the 
hepatoprotective activity of the plant. 
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